Gem Aromatics Ltd has officially begun production of cooling agents and clove-based products at its newly commissioned specialty molecules plant. With an investment of Rs 250 crore, the facility enhances the company’s portfolio in essential oils, aroma chemicals, and specialty derivatives, strengthening its position in the global fragrance and wellness market.
Gem Aromatics Ltd, a leading manufacturer of essential oils and aroma chemicals, announced the start of production at its new specialty molecules facility. The plant, commissioned in November 2025, adds significant capacity across multiple product lines, including cooling agents and clove derivatives. This expansion reflects the company’s strategy to diversify into high-value specialty ingredients catering to oral care, cosmetics, pharmaceuticals, and wellness industries.
Key highlights from the announcement include
-
The new facility represents an investment of approximately Rs 250 crore.
-
Production includes cooling agents, clove derivatives, and other specialty molecules such as MEHQ, BHA, Safranal, and Eugenol derivatives.
-
The cooling agents unit, with 500 MTPA capacity, is among the largest in India.
-
Clove-based products will cater to demand in oral care, nutraceuticals, and personal care markets.
-
The plant adds 10,829 MTPA of overall capacity across four segments.
-
Gem Aromatics aims to strengthen its global footprint in specialty aroma chemicals and essential oils.
-
Industry experts note that the expansion aligns with rising demand for natural and specialty ingredients worldwide.
This milestone underscores Gem Aromatics’ commitment to innovation and growth in the specialty chemicals sector. By diversifying into cooling agents and clove derivatives, the company is positioning itself to capture opportunities in both domestic and international markets.
Sources: SmallCapSpotlight, Gem Aromatics Investor Call Transcript, Tradejini IPO Overview